Angela Vitrano , Khaled M. Musallam , Antonella Meloni , Mehran Karimi , Shahina Daar , Paolo Ricchi , Silvia Costantini , Efthymia Vlachaki , Vito Di Marco , Amal El-Beshlawy , Mahmoud Hajipour , Saqib Hussain Ansari , Aldo Filosa , Adriana Ceci , Sylvia Titi Singer , Zaki A. Naserullah , Alessia Pepe , Filippo Cademartiri , Sebastiano Addario Pollina , Salvatore Scondotto , Aurelio Maggio
{"title":"Development of a Thalassemia International Prognostic Scoring System (TIPSS)","authors":"Angela Vitrano , Khaled M. Musallam , Antonella Meloni , Mehran Karimi , Shahina Daar , Paolo Ricchi , Silvia Costantini , Efthymia Vlachaki , Vito Di Marco , Amal El-Beshlawy , Mahmoud Hajipour , Saqib Hussain Ansari , Aldo Filosa , Adriana Ceci , Sylvia Titi Singer , Zaki A. Naserullah , Alessia Pepe , Filippo Cademartiri , Sebastiano Addario Pollina , Salvatore Scondotto , Aurelio Maggio","doi":"10.1016/j.bcmd.2022.102710","DOIUrl":null,"url":null,"abstract":"<div><p>A prognostic scoring system that can differentiate β-thalassemia patients based on mortality risk is lacking. We analysed data from 3145 β-thalassemia patients followed through a retrospective cohort design for the outcome of death. An <em>a priori</em><span> list of prognostic variables was collected. β Coefficients from a multivariate cox regression model were used from a development dataset (</span><em>n</em><span><span> = 2516) to construct a formula for a Thalassemia </span>International Prognostic Scoring System (TIPSS) which was subsequently applied to a validation dataset (</span><em>n</em><span><span> = 629). The median duration of observation was 10.0 years. The TIPSS score formula was constructed as exp (1.4 × heart disease + 0.9 × liver disease + 0.9 × diabetes + 0.9 × sepsis + 0.6 × alanine aminotransferase ≥42 IU/L + 0.6 × hemoglobin ≤9 g/dL + 0.4 × serum </span>ferritin ≥1850 ng/mL). TIPSS score thresholds of greatest differentiation were assigned as <2.0 (low-risk), 2.0 to <5.0 (intermediate-risk), and ≥5.0 (high-risk). The TIPSS score was a good predictor for the outcome of death in the validation dataset (AUC: 0.722, 95%CI: 0.641–0.804) and survival was significantly different between patients in the three risk categories (</span><em>P</em><span> < 0.001). Compared to low-risk patients, the hazard ratio for death was 2.778 (95%CI: 1.335–5.780) in patients with intermediate-risk and 6.431 (95%CI: 3.151–13.128) in patients with high-risk. This study provides a novel tool to support mortality risk categorization for patients with β-thalassemia that could help management and research decisions.</span></p></div>","PeriodicalId":8972,"journal":{"name":"Blood Cells Molecules and Diseases","volume":"99 ","pages":"Article 102710"},"PeriodicalIF":2.1000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Cells Molecules and Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1079979622000675","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 3
Abstract
A prognostic scoring system that can differentiate β-thalassemia patients based on mortality risk is lacking. We analysed data from 3145 β-thalassemia patients followed through a retrospective cohort design for the outcome of death. An a priori list of prognostic variables was collected. β Coefficients from a multivariate cox regression model were used from a development dataset (n = 2516) to construct a formula for a Thalassemia International Prognostic Scoring System (TIPSS) which was subsequently applied to a validation dataset (n = 629). The median duration of observation was 10.0 years. The TIPSS score formula was constructed as exp (1.4 × heart disease + 0.9 × liver disease + 0.9 × diabetes + 0.9 × sepsis + 0.6 × alanine aminotransferase ≥42 IU/L + 0.6 × hemoglobin ≤9 g/dL + 0.4 × serum ferritin ≥1850 ng/mL). TIPSS score thresholds of greatest differentiation were assigned as <2.0 (low-risk), 2.0 to <5.0 (intermediate-risk), and ≥5.0 (high-risk). The TIPSS score was a good predictor for the outcome of death in the validation dataset (AUC: 0.722, 95%CI: 0.641–0.804) and survival was significantly different between patients in the three risk categories (P < 0.001). Compared to low-risk patients, the hazard ratio for death was 2.778 (95%CI: 1.335–5.780) in patients with intermediate-risk and 6.431 (95%CI: 3.151–13.128) in patients with high-risk. This study provides a novel tool to support mortality risk categorization for patients with β-thalassemia that could help management and research decisions.
期刊介绍:
Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.